MannKind：新获批大幅提升发展前景（纳斯达克：MNKD）
· seekingalpha.com
三大收入来源持续为MannKind公司带来温和增长。下文将深入探讨MNKD股票为何被评为强力买入。
This is my first article on MannKind ( MNKD ), a developing commercial stage biotech with an ~$1.3 billion market cap. MannKind is enjoying a catalyst-rich 2026...